RecallRadar

FDA Drug recall D-0079-2022

Rizatriptan Benzoate Orally Disintegrating Tablets 5mg, 12 Tablets (2 x 6 Unit-Dose Tablets) Blister Packs, Rx only, Manufactured for: Macl…

On 2021-11-03 the FDA classified a Class III recall of Rizatriptan Benzoate Orally Disintegrating Tablets 5mg, 12 Tablets (2 x 6 Unit-Dose Tablets) Blister Packs, Rx only, Manufactured for: Macl… by Macleods Pharma Usa, citing out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0079-2022
ClassificationClass III
Statusterminated
Initiated2021-10-18
Published2021-11-03
Last updated2026-09-13 11:52 UTC
CompanyMacleods Pharma Usa
DistributionUS

Product

Rizatriptan Benzoate Orally Disintegrating Tablets 5mg, 12 Tablets (2 x 6 Unit-Dose Tablets) Blister Packs, Rx only, Manufactured for: Macleods Pharma USA Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA, NDC 33342-093-41

Reason

Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.

Identifiers

ndc33342-093-48
ndc33342-093-07
ndc33342-093-46
ndc33342-093-12
ndc33342-093-52
ndc33342-093-73
ndc33342-093-72
ndc33342-093-41
ndc33342-093-45
ndc33342-093-04
ndc33342-093-23
ndc33342-094-47
ndc33342-094-07
ndc33342-094-46
ndc33342-094-12
ndc33342-094-52
ndc33342-094-73
ndc33342-094-72
ndc33342-094-41
ndc33342-094-45
ndc33342-094-04
ndc33342-094-23
code_infoLot #: BRL2102A, BRL2103A, exp. date 04/2025

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0079-2022%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.